Posted by: Audrey Erbes | January 15, 2012

Insights on J.P. Morgan Healthcare Conference plus Upcoming Events

St. Francis Hotel

I found this year’s J.P. Morgan Healthcare Conference in San Francisco generally uninspiring with undercurrent of uncertainty at many levels. Missing were the start up companies and their passionate founders with reports of potential innovation that fired the imagination of attendees in the past. This circumstance has a lot to do with the departure of venture capital money for financing early stage start ups.

Big Pharma was focused on selling their stock so most of them sent their CFOs rather than CEOs to present their financials. The latters’ presentations lacked the sparkle of new marketing strategies and product launches. One felt the uncertainty in their strategic plans going forward as they scramble to change their business models to meet the challenges of losing blockbuster income and having lackluster pipelines.

I feel as if I am reliving history of the late 1990s when VC firms abandoned high risk biotech and biopharma and fled to investments in dot.coms.  Now they are fleeing to social media plays like Groupon. Perhaps this is good news in that more serious and experienced life science VCs who remain, as they did in late 1990s, will bring stability back to this sector. The profusion of new science and need for innovation just doesn’t support desertion of this sector.

See my guest blog including a detailed report and analysis of biopharma company presentations and meeting on the Pharmaceutical Executive blog . I suggest you also look at Windhover’s IN VIVO blog for additional insights. They promise to have more to say on the meeting soon. Right click on highlighted titles to link to websites mentioned.

There’s a settling down of events this coming week to the regularly scheduled ones with the following highlights:

  • BioCentury TV Today, See the Webcast Sunday, Jan. 15, 2012, Continuously available starting at 9:00 a.m. EDT through the week; Topic: “Crying for Change;” Speaker: FDA’s Janet Woodcock
  • Bio2Device Group, Tuesday Morning, Jan. 17, 2012; Topic: “NonClinical Safety Evaluation in Pharmaceutical Development;” Speaker: Michael Taylor, Ph.D., Principal, NonClinical Safety Assessment
  • BioScience Forum, Wednesday Evening, January 18th, 2012; Title: “Discovery, Development, and Potential Therapeutic Applications of Direct Sarcomere Activators;” Speaker: Fady Malik, MD, Ph.D., FACC, Vice President Biology and Therapeutics, Cytokinetics, Inc.
  • San Jose BioCenter, Tuesday Lunchtime, January 19, 2012; Topic: “All About Science-The Road to Biologic IND”
  • NCC ACRP Annual Planning Meeting, Saturday Morning, Jan. 21, 2012

But don’t forget to check out  the upcoming Personalized Medicine World Conference 2012 scheduled for Monday-Tuesday, Jan. 23-24, 2012 in Mountain View. This event occurs annually. See the details for this and all of Audrey’s Picks  through March by right clicking on highlighted title.




  1. […] Audrey Erbes had some insights on the Conference  as well as a blog on the PharmExec Blog site. […]

  2. […] Audrey Erbes had some insights on the Conference  as well as a blog on the PharmExec Blog site. […]

  3. Why users still use to read news papers when in this
    technological globe all is available on web?

    • I enjoy reading the paper with breakfast in the morning. I get tired of sitting in front of computer all day.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s


%d bloggers like this: